These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 39160490)

  • 1. Ten-year cardiovascular disease risk and related factors in lifetime marijuana use with comorbid methamphetamine-associated psychotic disorder: a QRISK
    Örüm D; Örüm MH; Kapıcı Y; Abuş S
    BMC Psychiatry; 2024 Aug; 24(1):563. PubMed ID: 39160490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-related psychotic symptoms in chronic methamphetamine users: evidence from a prospective longitudinal study.
    McKetin R; Lubman DI; Baker AL; Dawe S; Ali RL
    JAMA Psychiatry; 2013 Mar; 70(3):319-24. PubMed ID: 23303471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methamphetamine Use and Antipsychotic-related Extrapyramidal Side-effects in Patients with Psychotic Disorders.
    Temmingh HS; van den Brink W; Howells F; Sibeko G; Stein DJ
    J Dual Diagn; 2020; 16(2):208-217. PubMed ID: 31984872
    [No Abstract]   [Full Text] [Related]  

  • 4. Differences in the symptom profile of methamphetamine-related psychosis and primary psychotic disorders.
    McKetin R; Baker AL; Dawe S; Voce A; Lubman DI
    Psychiatry Res; 2017 May; 251():349-354. PubMed ID: 28282630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of substance use, psychosis, and mortality among people living in precarious housing or homelessness: A longitudinal, community-based study in Vancouver, Canada.
    Jones AA; Gicas KM; Seyedin S; Willi TS; Leonova O; Vila-Rodriguez F; Procyshyn RM; Smith GN; Schmitt TA; Vertinsky AT; Buchanan T; Rauscher A; Lang DJ; MacEwan GW; Lima VD; Montaner JSG; Panenka WJ; Barr AM; Thornton AE; Honer WG
    PLoS Med; 2020 Jul; 17(7):e1003172. PubMed ID: 32628679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risk and associated factors of methamphetamine psychosis in methamphetamine-dependent patients in Malaysia.
    Sulaiman AH; Said MA; Habil MH; Rashid R; Siddiq A; Guan NC; Midin M; Nik Jaafar NR; Sidi H; Das S
    Compr Psychiatry; 2014 Jan; 55 Suppl 1():S89-94. PubMed ID: 23433219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risks of psychosis in methamphetamine users: cross-sectional study in Thailand.
    Lamyai W; Pono K; Indrakamhaeng D; Saengsin A; Songhong N; Khuwuthyakorn P; Sribanditmongkol P; Junkuy A; Srisurapanont M
    BMJ Open; 2019 Oct; 9(10):e032711. PubMed ID: 31615802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polysubstance-induced relapse of schizoaffective disorder refractory to high-dose antipsychotic medications: a case report.
    Tucker MG; Kekulawala S; Kent M; Mostafa S; Harvey R
    J Med Case Rep; 2016 Sep; 10(1):242. PubMed ID: 27599617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiometabolic health risks, lifestyle behaviours and quality of life in people diagnosed with early psychosis - A cross-sectional study.
    Meepring S; Gray R; Li Y; Ho G; Chien WT; Bressington D
    J Psychiatr Ment Health Nurs; 2022 Aug; 29(4):578-591. PubMed ID: 34854171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How does a family history of psychosis influence the risk of methamphetamine-related psychotic symptoms: Evidence from longitudinal panel data.
    McKetin R; Clare PJ; Castle D; Turner A; Kelly PJ; Lubman DI; Arunogiri S; Manning V; Berk M
    Addiction; 2023 Oct; 118(10):1975-1983. PubMed ID: 37157055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methamphetamine-associated psychosis: links to drug use characteristics and similarity to primary psychosis.
    Yang M; Yang C; Liu T; London ED
    Int J Psychiatry Clin Pract; 2020 Mar; 24(1):31-37. PubMed ID: 31609149
    [No Abstract]   [Full Text] [Related]  

  • 12. Direction of the relationship between methamphetamine use and positive psychotic symptoms in regular methamphetamine users: evidence from a prospective cohort study.
    Hides L; Chan G; Dawe S; McKetin R; Kavanagh DJ; Young RM; Teesson M; Saunders JB
    Br J Psychiatry; 2021 Jul; 219(1):361-367. PubMed ID: 31950892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methamphetamine use and psychotic symptoms: findings from a New Zealand longitudinal birth cohort.
    Boden JM; Foulds JA; Newton-Howes G; McKetin R
    Psychol Med; 2023 Feb; 53(3):987-994. PubMed ID: 34134802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hospital separations for cannabis- and methamphetamine-related psychotic episodes in Australia.
    Degenhardt L; Roxburgh A; McKetin R
    Med J Aust; 2007 Apr; 186(7):342-5. PubMed ID: 17407429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics influencing age at onset in psychotic disorders.
    Ongür D; Lin L; Cohen BM
    Compr Psychiatry; 2009; 50(1):13-9. PubMed ID: 19059508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morbid risk for psychiatric disorder among the relatives of methamphetamine users with and without psychosis.
    Chen CK; Lin SK; Sham PC; Ball D; Loh el-W; Murray RM
    Am J Med Genet B Neuropsychiatr Genet; 2005 Jul; 136B(1):87-91. PubMed ID: 15892150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlates of transient versus persistent psychotic symptoms among dependent methamphetamine users.
    McKetin R; Gardner J; Baker AL; Dawe S; Ali R; Voce A; Leach LS; Lubman DI
    Psychiatry Res; 2016 Apr; 238():166-171. PubMed ID: 27086229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcomes in methamphetamine psychosis patients after first hospitalisation.
    Kittirattanapaiboon P; Mahatnirunkul S; Booncharoen H; Thummawomg P; Dumrongchai U; Chutha W
    Drug Alcohol Rev; 2010 Jul; 29(4):456-61. PubMed ID: 20636664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of methamphetamine psychosis: history of ADHD-relevant childhood behaviors and drug exposure.
    Salo R; Fassbender C; Iosif AM; Ursu S; Leamon MH; Carter C
    Psychiatry Res; 2013 Dec; 210(2):529-35. PubMed ID: 23896355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twelve-month course and outcome of methamphetamine-induced psychosis compared with first episode primary psychotic disorders.
    Hajebi A; Amini H; Kashani L; Sharifi V
    Early Interv Psychiatry; 2018 Oct; 12(5):928-934. PubMed ID: 27991722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.